These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19710671)

  • 1. Another bad break for proton-pump inhibitors?
    Targownik LE
    Nat Rev Rheumatol; 2009 Sep; 5(9):478-80. PubMed ID: 19710671
    [No Abstract]   [Full Text] [Related]  

  • 2. We Are Using Too Many PPIs, and We Need to Stop: A European Perspective.
    Lanas A
    Am J Gastroenterol; 2016 Aug; 111(8):1085-6. PubMed ID: 27166129
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proton pump inhibitor H2 receptor antagonist].
    Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
    Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25 Years of Proton Pump Inhibitors: A Comprehensive Review.
    Strand DS; Kim D; Peura DA
    Gut Liver; 2017 Jan; 11(1):27-37. PubMed ID: 27840364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concomitant use of proton pump inhibitors and systemic corticosteroids].
    Dorlo TP; Jager NG; Beijnen JH; Schellens JH
    Ned Tijdschr Geneeskd; 2013; 157(19):A5540. PubMed ID: 23657097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of proton pump inhibitor in the management of low dose aspirin related ulcerations].
    Hiraishi H; Shimada T
    Nihon Rinsho; 2010 Nov; 68(11):2096-101. PubMed ID: 21061539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peptic ulcer: facts and questions -- 2010].
    Hagymási K; Tulassay Z
    Orv Hetil; 2010 Jun; 151(26):1054-61. PubMed ID: 20558352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal safety of NSAIDs versus COX-2 inhibitors.
    Guslandi M
    Lancet; 2007 Apr; 369(9570):1344-1345. PubMed ID: 17448814
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention and treatment of nonsteroidal anti-inflammatory drugs induced ulcers].
    Kobayakawa M; Uemura N
    Nihon Rinsho; 2007 Oct; 65(10):1857-61. PubMed ID: 17926536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of high digestive hemorrhage on NSAID].
    Fratianni A; Ribeiro Da Costa R; Leung Ki EL; Drepper M
    Rev Med Suisse; 2020 Feb; 16(680):268-271. PubMed ID: 32022492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress ulcer prophylaxis: friend or foe?
    Macdonald JJ; Roberts JC; Washington S
    Br J Hosp Med (Lond); 2012 Apr; 73(4):238. PubMed ID: 22585209
    [No Abstract]   [Full Text] [Related]  

  • 13. Observational studies on prescription practices: interpret with caution.
    Savarino V; Dulbecco P
    Dig Liver Dis; 2010 May; 42(5):348-9. PubMed ID: 20356810
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes.
    Chou YS; Jiang HJ; Chen CH; Ho PS; Lee TC
    Sci Rep; 2020 Aug; 10(1):14081. PubMed ID: 32826941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor use among patients at risk of peptic ulcer bleeding: a nationwide register-based study.
    Haastrup PF; Hansen JM; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2021 Jan; 56(1):6-12. PubMed ID: 33280480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
    Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
    World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and Treatment of Peptic Ulcer Disease.
    Kavitt RT; Lipowska AM; Anyane-Yeboa A; Gralnek IM
    Am J Med; 2019 Apr; 132(4):447-456. PubMed ID: 30611829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
    Scally B; Emberson JR; Spata E; Reith C; Davies K; Halls H; Holland L; Wilson K; Bhala N; Hawkey C; Hochberg M; Hunt R; Laine L; Lanas A; Patrono C; Baigent C
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):231-241. PubMed ID: 29475806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-steroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury in Japan].
    Sugano K
    Nihon Shokakibyo Gakkai Zasshi; 2009 Mar; 106(3):321-6. PubMed ID: 19262045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.